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Abstract 
Background: Hepatitis B virus (HBV) infection causes chronic infection in human population, with high 
mortality. One of the high risk communities is mentally retarded children, who are institutionalized. Special 
conditions in these centers predispose children for HBV infection and transmission to healthy people. In this 
study our objective was to determine the prevalence of HBV infection among institutionalized mentally 
retarded children and study its associated risk factors. 
Materials and Methods: In this study, 250 mentally retarded children (younger than 14 years old) were 
included. They were living in 5 nursing institutions, located in different parts of Tehran. Hepatitis B surface 
antigen (HBsAg) was measured in the sera of these patients by ELISA method. 
Results: Among 250 children, 20 children (8%) were HBsAg positive. HBV infection in girls was more than 
boys (11% to 5.6%). Among the types of mental retardation, children with cerebral palsy had the highest 
positive result for HBsAg. The most HBV infection (28.5%) was seen in children with longest duration of 
being institutionalized (10 to 11 years). Vaccinated children were more HBsAg positive (8.7%) than non-
vaccinated children (5.3%). However, no significant relationship was observed between any of these factors 
and HBsAg positivity. 
Conclusion: Despite improvement of people’s health condition and implementation of HBV vaccination, the 
prevalence of HBV infection is increased in institutionalized mentally retarded children, which highlights the 
need for active measures to reduce this infection among this high risk population. 
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More than two billion of the world's population are 
exposed to hepatitis B virus (HBV)
1,2
 and 350 
million of them, (5% of the world population) are 
infected with HBV chronically
3
. HBV cause the most 
common chronic infection in human population and 
approximately 1 million people suffer from its 




Age of infection with HBV is inversely correlated to 
its chronicity. Risk of chronic disease is about 90% in 
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the prenatal cases, 50% in patients 1-5 years old and 
less than 5% in adults
5
. 
Iran is in the moderate prevalence zone of infection 
with HBV. Since 1993, neonates are vaccinated 
against this virus, which has led to reduction of the 




However, many factors, in different populations, are 
involved in the prevalence of hepatitis B that 
interferes with the control of the virus spread. One of 
these factors is living in special communities, with 
different lifestyle and different physical and behavior 
characteristics, which is the reason of increased 
incidence of the infection comparing normal 
population. One of this special communities is 
institutionalized mentally retard children. Several 
reports have shown that people who live in crowded 
centers such as institutionalized mentally retarded 
children or old people living in nursing homes are at 




High prevalence of hepatitis B infection in these 
people has several reasons, such as frequent contact 
with blood and body fluids of infected subjects as a 
result of overpopulation of institutions, having shared 
nurse and so increased communication between 
patients and healthy subjects, inappropriate patients’ 
hygiene,and aggressive behaviors among these 
children, such as biting
10,11
. 
In addition, children with intellectual disability, such 
as Down syndrome, may also suffer from partial 
immunodeficiency
7
 and abnormal activity of the 
thyroid gland
12
, which increases the risk of 
developing infections. The duration of being 
institutionalized has also direct relationship with the 
prevalence of infection in these patients
8
. The 
frequent use of antiepileptic drugs can suppress 
immune system and cause weak response to 
vaccines, which in turn leads to increased prevalence 
of chronic hepatitis B, cirrhosis and liver cancer in 
mentally retarded children. 
Only study in this field in Iran is the study done in 
2003 about prevalence of HBV infection among 
institutionalized mentally retarded children
12
. 
However, the presence of factors such as weak 
immune system, possibility of formation of vaccine 
escape strains, high-risk behaviors and risk factors 
among these patients highlights the need for a new 
and detailed study. So, we aimd to determine the status 
of HBV infection among mentally retarded children 
after 10 years and examined the risk factors of HBV 
infection in these children. 
Methods 
In this study, 250 mentally retarded children (younger 
than 14 years old) were included. They were living in 
5 nursing institutions, located in different parts of 
Tehran. Also, the consent form was filled in by their 
parents or the supervisor of those centers for sample 
collection. 
The patients’ information, such as age, sex, type of 
disability, duration of being institutionalized, and 
HBV vaccination history were recorded in a 
questionnaire. Five milli liter bloods was collected 
from each patient and after separation, the sera were 
stored in -20C, until the time of the tests. Presence of 
Hepatitis B surface antigen (HbsAg) in patients’ serum 
was evaluated with ELISA assay (specificity>99%), 
using DIA PRO kit (Milano, Italy). The test was done 
according to the manufacturer’s instruction. The data 
was analyzed, using SPSS 16.0 software. 
Results 
Among 250 children, 141(56.4%) were boys and 109 
(43.6%) were girls. The mean and standard deviation 
of age were 9.4±4.2 years. In terms of disability, 13 
(5.2%) had Autism, 42 (16.8%) had cerebral palsy 
(CP), 47 (18.7%) had Down’s syndrome (DS), and 
148 (59.2%) had other types of mental retardation 
(MR). Duration of being institutionalized ranged from 
1 to 11 years. More than 75% of the children had a 
history of being institutionalized less than 5 years and 
the rest of them have been institutionalized for 6 to 11 
years. According to their records, 194 children 
(77.6%) were vaccinated against HBV and 56 children 
(22.4%) were not vaccinated or their vaccination 
history was not available. The patients’ characteristics 
are summarized in table 1. 20 children (8%) were 
positive for HBsAg. 
Among the infected children, 8 (40%) were boys and 
12 (60%) were girls. HBsAg positivity rate was 6.5% 
among boys and 11% among girls, but there was no 
significant association between the gender of the 
patients and being HBs Ag positive (P>0.05).  
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The most positive results for HBsAg were seen in 
children 3 to 4 years. Among 14 children 3 to 4 years 
old, 4 (28%) were HBsAg positive (Table 1), but 
here was no significant association between the 
presence of HBsAg and age (P>0.05). 
CP children had the most HBsAg positivity, but there 
was no relationship between HBsAg positivity and 
type of mental disability (P>0.05). Among 42 
children with CP, 5 (11.9%) were HBsAg positive. In 
children with Autism 7.6%, MR 7.4%, and DS 6.3% 
were HBsAg positive. 
Among institutions included in this study, center 
number 4 had the most children with positive HBsAg 
(12.7%). HBsAg was positive in 9.5% of children in 
center 1, 11.7% in center 2, and 4% in center 3. There 
was no HBsAg positive child in center 5. There was 
no significant relationship between the institution the 
children were living and of HBsAg positivity 
(P>0.05). 
As shown in table 2, most children with positive 
HBsAg (28.5%) were those with longest stay in 
institutions (10 to 11 years), but here was no 
significant association between HBsAg and length of 
their stay (P>0.05). 
Table 1: The characteristic of the study subjects. 
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Among 194 children, who were vaccinated against 
HBV, 17 children (8.7%) were HBsAg positive, 
while among 53 non-vaccinated children, only 3 
(5.3%) were HBsAg positive. There was no 
significant relationship between vaccination history 
of these patients and positive HBsAg (P>0.05). 
Discussion 
Numerous studies worldwide have reported high 
prevalence of HBV infection in mentally retarded 
children and have shown that many factors contribute 
to this high incidence
11,13
. 
Among these studies, a study in 1975 in Canada, on 
institutionalized mentally retarded children reported 
the high prevalence of HBV infection among patients 
with Down syndrome comparing other types of mental 
retardations and normal population
9
. The evaluated 
risk factors in this study were age, sex, and length of 
stay. Although this study didn’t report significant 
difference between girls and boys in HBV infection, it 
suggested that being institutionalized from young age 
is the most important factor in increasing the risk of 
HBV infection. In our study, although HBsAg was 
positive in girls twice than boys, there was no 
significant association between sex and positive 
HBsAg. The most positive HBsAg result (28%) was 
reported among children 3-4 years old. 
A study in 1992 in Spain
14
, carried out to evaluate 
differences in the prevalence of positive HBsAg in two 
groups of patients with Down syndrome and other 
Table 2: The results of HBsAg test in different age 
groups in institutionalized mentally retarded children. 










10 0 0 10 0-1 
7 14 1 6 1-2 
11 9 1 10 2-3 
14 28 4 10 3-4 
20 5 1 19 4-5 
14 7 1 13 5-6 
12 0 0 12 6-7 
10 0 0 10 7-8 
13 8 1 12 8-9 
11 0 0 11 9-10 
20 5 1 19 10-11 
24 8 2 22 11-12 
19 11 2 17 12-13 
65 9 6 59 13-14 
 
















52 9.6 5 47 0-1 
49 12.2 6 43 1-2 
27 5.4 2 35 2-3 
32 3.1 1 31 3-4 
29 0 0 29 4-5 
10 0 0 10 5-6 
8 12.5 1 7 6-7 
11 0 0 11 7-8 
2 0 0 2 8-9 
6 16.6 1 5 9-10 
14 28.5 4 10 10-11 
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mental retardations, it was reported that 26% of 
patients with Down syndrome and 8% of patients 
with other mental retardations were infected with 
HBV. In another study in 1975 in Canada
9
, the 
prevalence of positive HBsAg in patients with Down 
syndrome was reported 34.8% and in other mental 
retardations 5.3%. Dutch researchers
15
 also reported 
direct association between prevalence of HBV 
infection and type of disability, with high prevalence 
HBV infection in Down syndrome comparing other 
mental retardations. In the present study, although we 
observed no significant association between type of 
disability and positive HBsAg, high HBV infection 
(11.9%) was reported in CP children. Only 6.3% of 
children with Down syndrome were HBsAg positive. 
In other studies including a study in 1999 in 
Belgium
16
 and in 2000 in Spain
17
, the duration of 
being institutionalized was reported as a risk factor of 
HBV infection. In our study, although no signifiant 
association was observed between positivity of 
HBsAg and the duration of being institutionalized, 
the highest HBV infection rate (28.5%) was observed 
in children with longest period of being 
institutionalized (10-11 years). In a similar study in 
2004 in Brazil
18
, duration of being institutionalized 
and multiple admissions in institutions were reported 
as the major risk factors for increased prevalence of 
HBV among institutionalized mentally retarded 
children.  
In this study, no significant relationship was 
observed between history of vaccination and 
positivity of HBsAg and in contrary to our 
expectations, we noticed a higher infection rate in 
vaccinated children comparing non-vaccinated 
children (7.8% to 3.5%). This is probably due to the 
infection of these children with mutant strains of 
HBV that could be resistant to immune response and 
vaccine. A study in 1998 in Singapore
19
 showed that 
mutation in HBsAg happens more (in number and 
severity) in vaccinated children comparing non-
vaccinated children. 
In the only study in Iran, which was done in 2003
10
, 
the prevalence of HBV infection among mentally 
retarded children was reported 6%. In the present 
study, 8% of mentally retarded children were HBsAg 
positive. Despite a dramatic improvement in people’s 
health condition and the implementation of HBV 
vaccination program for children in this period, this 
shows an increase in HBV infections in 10 years.  
According to these results, the prevalence of HBV 
infection in these children is even more than some 
high-risk populations such as blood recipients
20,21
 or 





in Iran, HBV infection in intravenous drug users was 
reported 6% and 5.8% respectively, which has 
decreased to 3.2–3.3% nowadays
24,25
. This decrease is 
due to education and executing preventive measures in 
intravenous drug users
23
. It seems that specific 
conditions of children with mental retardation, 
particularly their special isolation and poor health 
situation have resulted in an increased incidence of 
HBV infection among them, despite the vaccination 
program done by ministry of Health.  
Conclusion 
According to the results of our study, it is essential to 
change some health policies in mentally retarded 
children in Iran to reduce HBV infection among this 
high risk population. More attention should be paid to 
these children and other studies like measurement of 
HBsAb and evaluation of immune response to HBV 
vaccine in these children should be done in next steps. 
In addition, identification of mutations in hepatitis B 
surface gene, which can be a cause for escape from 
immune response to vaccination, has an important 
role. This subject is helpful in finding the causes of the 
high HBV infection rate among the population and the 
consequent control of HBV infection. 
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